Latest MagVenture News & Updates

See the latest news and media coverage for MagVenture. We track all announcements, press releases, and industry mentions in real time, all in one place.

MagVenture

Manufacturer of transcranial magnetic stimulation systems

magventure.com

Headquarters: Farum, Denmark
Founded year: 1992
Company type: Private company
Number of employees: 200–500

Last updated Today

Latest news about MagVenture

In short: MagVenture expanded its portfolio with new FDA clearances for PTSD and adolescent depression treatments while launching portable TMS technology.

Company announcements

June 19 MagVenture

MagVenture announces FDA-cleared PTSD treatment using MeRT

Wave Neuroscience's EEG-guided TMS approach received FDA clearance for adjunct PTSD treatment, delivered on MagVenture systems.

June 4 MagVenture

MagVenture introduces aTMS for faster depression treatment

Accelerated TMS completes protocols in days instead of weeks, maintaining FDA clearance and efficacy.

May 26 MagVenture

MagVenture receives FDA clearance for accelerated TMS protocols

The clearance enables multiple TMS sessions per day, reducing treatment duration from weeks to days while maintaining safety and effectiveness.

April 17 MagVenture

MagVenture announces Lancet Psychiatry publication of MST trial results

The large randomized trial shows MST is non-inferior to ECT for depression remission with better cognitive safety. It involved 236 participants.

Media coverage

June 18 The Oklahoman

MagVenture Announces FDA Clearance of Wave Neuroscience's MeRT® System for PTSD, delivered on MagVenture® Technology

Wave's FDA clearance of MeRT® for PTSD marks an important advancement for patients whose lives have been shaped by...

April 16 EurekAlert!

Large confirmatory clinical trial shows efficacy and safety of new brain stimulation therapy for depression

A landmark international clinical trial led by researchers at the Centre for Addiction and Mental Health (CAMH) and University of California San Diego School of...

March 5 Journal of Neurology, Neurosurgery & Psychiatry

A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCI

Background Emerging evidence suggests that repetitive transcranial magnetic stimulation (rTMS) enhances cognition in mild cognitive impairment (MCI). Accelerated intermittent theta burst stimulation (iTBS) rTMS protocols...

2 September 2025 KOIN 6

FDA Expands MagVenture TMS Indications to Treat MDD, OCD, and Anxious Depression with One Coil

With this expanded portfolio, our users can now choose the most appropriate coil for each specific patient, prioritizing comfort, treatment precision, and outcomes." — Kerry...

Never miss news about MagVenture

Track MagVenture and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

MagVenture competitors & trending companies

Browse news for competitors to MagVenture and other trending companies.